Loading provider…
Loading provider…
Medical Oncology Physician in Tampa, FL
NPI: 1013960988Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get MD Jonathan's Phone Numberphone_androidMobile
Get MD Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2003 - 2027
DC State Medical License
2002 - 2004
MT State Medical License
2003 - 2004
VA State Medical License
2000 - 2004

American Board of Internal Medicine
Medical Oncology
MedStar Health Georgetown University/Georgetown Hospital
Residency • Internal Medicine
1999 - 2002
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
Fellowship • Hematology and Medical Oncology
2003 - 2006
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 156 | 202 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 109 | 168 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 34 | 34 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 23 | 28 |
Authors: Thomas Abrams, Larry Kvols, Jennifer Chan
Journal: Endocr Relat Cancer
Publication Date: 2013-05-21
Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade.
Authors: Al-Toubah, Taymeyah, Strosberg, Jonathan, Hallanger-Johnson, Julie, El-Haddad, Ghassan
Journal: Front Endocrinol (Lausanne)
Publication Date: 2023-11-20
Determining the optimal number of lymph nodes harvested during esophagectomy.
Authors: Kenneth Meredith, Sarah Hoffe, Khaldoun Almhanna, Ravi Shridhar
Journal: J Gastrointest Oncol
Lead Sponsor: ITM Solucin GmbH
Intervention / Treatment: DRUG: Everolimus, DRUG: FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin), OTHER: Amino-Acid Solution, DRUG: 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, DRUG: CAPTEM (Capecitabine and Temozolomide)
Lead Sponsor: Advanced Accelerator Applications
Intervention / Treatment: DRUG: Lutathera, DRUG: 30 mg Octreotide long acting repeatable (LAR) (Sandostatin LAR Depot), DRUG: 2.5% Lys-Arg sterile amino acid solution, DRUG: High dose 60 mg octreotide long-acting repeatable
Lead Sponsor: AC Camargo Cancer Center
Collaborators: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DRUG: Tamoxifen